Clinical Trial of the COVID-19 Vaccine (Recombinant, Inactivated) in Brazil

NCT04993209 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

320

Enrollment

OTHER_GOV

Sponsor class

Conditions

Coronavirus Infections
Healthy

Interventions

BIOLOGICAL: NDV-HXP-S 1μg
BIOLOGICAL: NDV-HXP-S 3μg
BIOLOGICAL: NDV-HXP-S 10μg
OTHER: Adsorbed inactivated COVID-19 vaccine (CoronaVac)

Sponsor

Butantan Institute